Non-alcoholic Steatohepatitis Market Report

Global and Region Non-alcoholic Steatohepatitis Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：229
  • REPORT CODE：GMM959061
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Non-alcoholic Steatohepatitis market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Non-alcoholic Steatohepatitismarket, defines the market attractiveness level of Non-alcoholic Steatohepatitis market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Non-alcoholic Steatohepatitis industry, describes the types of Non-alcoholic Steatohepatitis market, the applications of major players and the market size, and deeply analyzes the current situation of the global Non-alcoholic Steatohepatitis market and the development prospects and opportunities of Non-alcoholic Steatohepatitis industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Non-alcoholic Steatohepatitis market in Chapter 13.

    By Player:

    • Roche

    • Arisaph Pharmaceuticals

    • Cempra Pharmaceuticals

    • Interceptpharma

    • Novo Nordisk

    • Viking Therapeutics

    • AstraZeneca

    • Raptor Pharmaceutical

    • Tobira Therapeutics

    • Genfit

    • Galectin Therapeutics

    • GSK

    • Galmed Pharmaceuticals

    • Verva

    • Vivus

    • Immuron

    • Gilead

    • Arena Pharmaceuticals

    • Shire

    By Type:

    • Hypertension

    • Heart Disease

    • High Blood Lipid

    • Type 2 Diabetes

    • Obesity

    By End-User:

    • Hospitals

    • Clinics

    • Homecare Settings

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Non-alcoholic Steatohepatitis Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Non-alcoholic Steatohepatitis Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Non-alcoholic Steatohepatitis Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Non-alcoholic Steatohepatitis Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Non-alcoholic Steatohepatitis Market Analysis and Outlook to 2022

    • 7.1 Global Non-alcoholic Steatohepatitis Consumption (2017-2022)

    • 7.2 United States Non-alcoholic Steatohepatitis Consumption (2017-2022)

    • 7.3 Europe Non-alcoholic Steatohepatitis Consumption (2017-2022)

    • 7.4 China Non-alcoholic Steatohepatitis Consumption (2017-2022)

    • 7.5 Japan Non-alcoholic Steatohepatitis Consumption (2017-2022)

    • 7.6 India Non-alcoholic Steatohepatitis Consumption (2017-2022)

    • 7.7 South Korea Non-alcoholic Steatohepatitis Consumption (2017-2022)

    8 Region and Country-wise Non-alcoholic Steatohepatitis Market Analysis and Outlook to 2028

    • 8.1 Global Non-alcoholic Steatohepatitis Consumption Forecast (2022-2028)

    • 8.2 United States Non-alcoholic Steatohepatitis Consumption Forecast (2022-2028)

    • 8.3 Europe Non-alcoholic Steatohepatitis Consumption Forecast (2022-2028)

    • 8.4 China Non-alcoholic Steatohepatitis Consumption Forecast (2022-2028)

    • 8.5 Japan Non-alcoholic Steatohepatitis Consumption Forecast (2022-2028)

    • 8.6 India Non-alcoholic Steatohepatitis Consumption Forecast (2022-2028)

    • 8.7 South Korea Non-alcoholic Steatohepatitis Consumption Forecast (2022-2028)

    9 Global Non-alcoholic Steatohepatitis Market Outlook by Types and Applications to 2022

    • 9.1 Global Non-alcoholic Steatohepatitis Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Hypertension Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Heart Disease Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global High Blood Lipid Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Type 2 Diabetes Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Obesity Consumption and Growth Rate (2017-2022)

    • 9.2 Global Non-alcoholic Steatohepatitis Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Homecare Settings Consumption and Growth Rate (2017-2022)

    10 Global Non-alcoholic Steatohepatitis Market Outlook by Types and Applications to 2028

    • 10.1 Global Non-alcoholic Steatohepatitis Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Hypertension Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Heart Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global High Blood Lipid Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Obesity Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Non-alcoholic Steatohepatitis Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Homecare Settings Consumption Forecast and Growth Rate (2022-2028)

    11 Global Non-alcoholic Steatohepatitis Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Non-alcoholic Steatohepatitis Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Non-alcoholic Steatohepatitis Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Non-alcoholic Steatohepatitis Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Non-alcoholic Steatohepatitis Market Competitive Analysis

    • 14.1 Roche

      • 14.1.1 Roche Company Details

      • 14.1.2 Roche Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Roche Non-alcoholic Steatohepatitis Product and Service

    • 14.2 Arisaph Pharmaceuticals

      • 14.2.1 Arisaph Pharmaceuticals Company Details

      • 14.2.2 Arisaph Pharmaceuticals Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Arisaph Pharmaceuticals Non-alcoholic Steatohepatitis Product and Service

    • 14.3 Cempra Pharmaceuticals

      • 14.3.1 Cempra Pharmaceuticals Company Details

      • 14.3.2 Cempra Pharmaceuticals Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Cempra Pharmaceuticals Non-alcoholic Steatohepatitis Product and Service

    • 14.4 Interceptpharma

      • 14.4.1 Interceptpharma Company Details

      • 14.4.2 Interceptpharma Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Interceptpharma Non-alcoholic Steatohepatitis Product and Service

    • 14.5 Novo Nordisk

      • 14.5.1 Novo Nordisk Company Details

      • 14.5.2 Novo Nordisk Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Novo Nordisk Non-alcoholic Steatohepatitis Product and Service

    • 14.6 Viking Therapeutics

      • 14.6.1 Viking Therapeutics Company Details

      • 14.6.2 Viking Therapeutics Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Viking Therapeutics Non-alcoholic Steatohepatitis Product and Service

    • 14.7 AstraZeneca

      • 14.7.1 AstraZeneca Company Details

      • 14.7.2 AstraZeneca Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 AstraZeneca Non-alcoholic Steatohepatitis Product and Service

    • 14.8 Raptor Pharmaceutical

      • 14.8.1 Raptor Pharmaceutical Company Details

      • 14.8.2 Raptor Pharmaceutical Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Raptor Pharmaceutical Non-alcoholic Steatohepatitis Product and Service

    • 14.9 Tobira Therapeutics

      • 14.9.1 Tobira Therapeutics Company Details

      • 14.9.2 Tobira Therapeutics Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Tobira Therapeutics Non-alcoholic Steatohepatitis Product and Service

    • 14.10 Genfit

      • 14.10.1 Genfit Company Details

      • 14.10.2 Genfit Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Genfit Non-alcoholic Steatohepatitis Product and Service

    • 14.11 Galectin Therapeutics

      • 14.11.1 Galectin Therapeutics Company Details

      • 14.11.2 Galectin Therapeutics Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Galectin Therapeutics Non-alcoholic Steatohepatitis Product and Service

    • 14.12 GSK

      • 14.12.1 GSK Company Details

      • 14.12.2 GSK Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 GSK Non-alcoholic Steatohepatitis Product and Service

    • 14.13 Galmed Pharmaceuticals

      • 14.13.1 Galmed Pharmaceuticals Company Details

      • 14.13.2 Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Product and Service

    • 14.14 Verva

      • 14.14.1 Verva Company Details

      • 14.14.2 Verva Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Verva Non-alcoholic Steatohepatitis Product and Service

    • 14.15 Vivus

      • 14.15.1 Vivus Company Details

      • 14.15.2 Vivus Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Vivus Non-alcoholic Steatohepatitis Product and Service

    • 14.16 Immuron

      • 14.16.1 Immuron Company Details

      • 14.16.2 Immuron Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Immuron Non-alcoholic Steatohepatitis Product and Service

    • 14.17 Gilead

      • 14.17.1 Gilead Company Details

      • 14.17.2 Gilead Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Gilead Non-alcoholic Steatohepatitis Product and Service

    • 14.18 Arena Pharmaceuticals

      • 14.18.1 Arena Pharmaceuticals Company Details

      • 14.18.2 Arena Pharmaceuticals Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Arena Pharmaceuticals Non-alcoholic Steatohepatitis Product and Service

    • 14.19 Shire

      • 14.19.1 Shire Company Details

      • 14.19.2 Shire Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Shire Non-alcoholic Steatohepatitis Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Non-alcoholic Steatohepatitis

    • Figure Non-alcoholic Steatohepatitis Picture

    • Table Global Non-alcoholic Steatohepatitis Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Non-alcoholic Steatohepatitis Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Non-alcoholic Steatohepatitis Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Non-alcoholic Steatohepatitis Consumption by Country (2017-2022)

    • Figure United States Non-alcoholic Steatohepatitis Consumption and Growth Rate (2017-2022)

    • Table Europe Non-alcoholic Steatohepatitis Consumption and Growth Rate (2017-2022)

    • Figure China Non-alcoholic Steatohepatitis Consumption and Growth Rate (2017-2022)

    • Figure Japan Non-alcoholic Steatohepatitis Consumption and Growth Rate (2017-2022)

    • Figure India Non-alcoholic Steatohepatitis Consumption and Growth Rate (2017-2022)

    • Figure South Korea Non-alcoholic Steatohepatitis Consumption and Growth Rate (2017-2022)

    • Figure Global Non-alcoholic Steatohepatitis Consumption Forecast by Country (2022-2028)

    • Figure United States Non-alcoholic Steatohepatitis Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Non-alcoholic Steatohepatitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Non-alcoholic Steatohepatitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Non-alcoholic Steatohepatitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Non-alcoholic Steatohepatitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Non-alcoholic Steatohepatitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hypertension Consumption and Growth Rate (2017-2022)

    • Figure Global Heart Disease Consumption and Growth Rate (2017-2022)

    • Figure Global High Blood Lipid Consumption and Growth Rate (2017-2022)

    • Figure Global Type 2 Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Global Obesity Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Homecare Settings Consumption and Growth Rate (2017-2022)

    • Figure Global Hypertension Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Heart Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global High Blood Lipid Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type 2 Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Obesity Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Homecare Settings Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Non-alcoholic Steatohepatitis Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Non-alcoholic Steatohepatitis Export by Region (Top 5 Countries) (2017-2028)

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Non-alcoholic Steatohepatitis Product and Service

    • Table Arisaph Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Arisaph Pharmaceuticals Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arisaph Pharmaceuticals Non-alcoholic Steatohepatitis Product and Service

    • Table Cempra Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Cempra Pharmaceuticals Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cempra Pharmaceuticals Non-alcoholic Steatohepatitis Product and Service

    • Table Interceptpharma (Foundation Year, Company Profile and etc.)

    • Table Interceptpharma Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Interceptpharma Non-alcoholic Steatohepatitis Product and Service

    • Table Novo Nordisk (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk Non-alcoholic Steatohepatitis Product and Service

    • Table Viking Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Viking Therapeutics Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Viking Therapeutics Non-alcoholic Steatohepatitis Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Non-alcoholic Steatohepatitis Product and Service

    • Table Raptor Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Raptor Pharmaceutical Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Raptor Pharmaceutical Non-alcoholic Steatohepatitis Product and Service

    • Table Tobira Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Tobira Therapeutics Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tobira Therapeutics Non-alcoholic Steatohepatitis Product and Service

    • Table Genfit (Foundation Year, Company Profile and etc.)

    • Table Genfit Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genfit Non-alcoholic Steatohepatitis Product and Service

    • Table Galectin Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Galectin Therapeutics Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Galectin Therapeutics Non-alcoholic Steatohepatitis Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Non-alcoholic Steatohepatitis Product and Service

    • Table Galmed Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Galmed Pharmaceuticals Non-alcoholic Steatohepatitis Product and Service

    • Table Verva (Foundation Year, Company Profile and etc.)

    • Table Verva Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Verva Non-alcoholic Steatohepatitis Product and Service

    • Table Vivus (Foundation Year, Company Profile and etc.)

    • Table Vivus Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vivus Non-alcoholic Steatohepatitis Product and Service

    • Table Immuron (Foundation Year, Company Profile and etc.)

    • Table Immuron Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Immuron Non-alcoholic Steatohepatitis Product and Service

    • Table Gilead (Foundation Year, Company Profile and etc.)

    • Table Gilead Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Non-alcoholic Steatohepatitis Product and Service

    • Table Arena Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Arena Pharmaceuticals Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arena Pharmaceuticals Non-alcoholic Steatohepatitis Product and Service

    • Table Shire (Foundation Year, Company Profile and etc.)

    • Table Shire Non-alcoholic Steatohepatitis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shire Non-alcoholic Steatohepatitis Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US